PERLEGEN, PNDRC TO COLLABORATE ON BIPOLAR DISORDER STUDY
Perlegen Sciences is conducting a high-density, whole genome association study of bipolar disorder (BPD) in collaboration with the Pritzker Neuropsychiatric Disorders Research Consortium (PNDRC).
DNA samples systematically collected by projects that participated in the National Institute of Mental Health (NIMH) Bipolar Disorder Genetics Initiative and control samples from the NIMH Molecular Genetics of Schizophrenia (MGS-2) Initiative will be used in the study. This effort represents a convergence of resources from the commercial, academic, federal and philanthropic sectors aimed at discovering the causes of psychiatric disorders and devising novel treatments.
The collaborators will conduct a comparative study of genetic variation in patients with BPD versus matched, unaffected controls. The genetic variants, also called single nucleotide polymorphisms, will be genotyped in the cases and controls. Validation of results will be conducted in a separate set of BPD cases and controls.
Upcoming Events
-
21Oct